Standard 7 - Audit Report

CLINICAL GOVERNANCE AND QUALITY IMPROVEMENT TO SUPPORT BLOOD MANAGEMENT
Integrating clinical governance

7.1 Clinicians use the safety and quality systems from the Clinical Governance Standard when:
a. Implementing policies and procedures for blood management
b. Managing risks associated with blood management
c. Identifying training requirements for blood management

Applying quality improvement systems

7.2 The health service organisation applies the quality improvement system from the Clinical Governance Standard when:
a. Monitoring the performance of the blood management system
b. Implementing strategies to improve blood management and associated processes
c. Reporting on the outcomes of blood management

Partnering with consumers

7.3 Clinicians use organisational processes from the Partnering with Consumers Standard when providing safe blood management to:
a. Actively involve patients in their own care
b. Meet the patient’s information needs
c. Share decision-making

PRESCRIBING AND CLINICAL USE OF BLOOD AND BLOOD PRODUCTS
Optimising and conserving patients’ own blood

7.4 Clinicians use the blood and blood products processes to manage the need for, and minimise the inappropriate use of, blood and blood products by:
a. Optimising patients’ own red cell mass, haemoglobin and iron stores
b. Identifying and managing patients with, or at risk of, bleeding
c. Determining the clinical need for blood and blood products, and related risks

Documentation

7.5 Clinicians document decisions relating to blood management, transfusion history and transfusion details in the healthcare record

Prescribing and administering blood and blood products

7.6 The health service organisation supports clinicians to prescribe and administer blood and blood products appropriately, in accordance with national guidelines and national criteria

Reporting adverse events

7.7 The health service organisation uses processes for reporting transfusionrelated adverse events, in accordance with national guidelines and criteria

7.8 The health service organisation participates in haemovigilance activities, in accordance with the national framework

MANAGING THE AVAILABILITY AND SAFETY OF BLOOD AND BLOOD PRODUCTS
Storing, distributing and tracing blood and blood products

7.9 The health service organisation has processes:
a. That comply with manufacturers’ directions, legislation, and relevant jurisdictional requirements to store, distribute and handle blood and blood products safely and securely
b. To trace blood and blood products from entry into the organisation to transfusion, discard or transfer

Availability of blood

7.10 The health service organisation has processes to:
a. Manage the availability of blood and blood products to meet clinical need
b. Eliminate avoidable wastage
c. Respond in times of shortage

Please note that this checklist is a hypothetical example and provides basic information only. It is not intended to take the place of, among other things, workplace, health and safety advice; medical advice, diagnosis, or treatment; or other applicable laws. You should also seek your own professional advice to determine if the use of such checklist is permissible in your workplace or jurisdiction.